Abstract
Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies against the acetylcholine receptor (AChR) at the neuromuscular junction [1]. The muscular AChR has been extensively characterized [2], but the etiology of MG is still obscure. Whether the muscular AChR or another (auto)antigen plays a role during the initiation of MG is unknown [3]. The muscular AChR is a pentameric ion channel composed of four different subunits. The α-subunit contains the acetylcholine binding site and the main epitopes recognized by MG autoantibodies [2]. The human muscle AChR α-subunit exists as two isoforms, P3A- and P3A+ [4]. This is a result of alternative splicing of the P3A exon located between exons three and four. The P3A+ isoform does not bind α-bungarotoxin or monoclonal antibodies against the AChR main immunogenic region and is not integrated into functional AChR [5]. The muscular AChR belongs to the family of nicotinic AChRs as do neuronal AChRs. Since muscular and neuronal AChRs share significant molecular homology [6], neuronal AChRs have been considered as candidate autoantigens able to elicit autoimmunity against the muscular AChR by molecular mimicry [7].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Lindstrom, J., D. Shelton and Y. Fujii. 1988. Myasthenia gravis. Adv. Immunol. 42: 233.
Tzartos, S.J., T. Barkas, M.T. Cung, A. Mamalaki, M. Marraud, P. Orlewski, D. Papanastasiou, C. Sakarellos, M. Sakarellos-Daitsiotis, P. Tsantili and V. Tsikaris. 1998. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol. Rev. 163: 89–120: 89.
Vincent, A. 1994. Aetiological factors in development of myasthenia gravis. Adv. Neuroimmunol. 4: 355.
Beeson, D., A. Morris, A. Vincent and J. Newsom Davis. 1990. The human muscle nicotinic acetylcholine receptor alpha-subunit exist as two isoforms: a novel exon. EMBO. J. 9: 2101.
Newland, C.F., D. Beeson, A. Vincent and J. Newsom-Davis. 1995. Functional and non-functional isoforms of the human muscle acetylcholine receptor. J. Physiol. (Lond). 489: 767.
Lindstrom, J. 1996. Neuronal nicotinic acetylcholine receptors. In Ion channels. T. Narahashi, ed. Plenum Press, New York, p. 377.
Mihovilovic, M. and A.D. Roses. 1993. Expression of alpha-3, alpha-5 and beta-4 neuronal acetylcholine receptor subunit transcripts in normal and myasthenia gravis thymus. Identification of thymocytes expressing the alpha-3 transcripts. J. Immunol. 151: 6517.
Willcox, N. 1993. Myasthenia gravis. Curr. Opin. Immunol. 5: 910.
Sommer, N., G.C. Harcourt, N. Willcox, D. Beeson and J. Newsom Davis. 1991. Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurology 41: 1270.
Meinl, E., W.E. Klinkert and H. Wekerle. 1991. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat. Am. J. Pathol. 139: 995.
Schluep, M., N. Willcox, A. Vincent, G.K. Dhoot and J. Newsom-Davis. 1987. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann. Neurol. 22: 212.
Wekerle, H. and U. P. Ketelsen. 1977. Intrathymic pathogenesis and dual genetic control of myasthenia gravis. Lancet. 1: 678.
Müller-Hermelink, H.K., A. Wilisch, A. Schultz and A. Marx. 1997. Characterization of the human thymic microenvironment: Lymphoepithelial interaction in normal thymus and thymoma. Arch. of Hist. and Cyt. 60: 9.
Nenninger, R., A. Schultz, V. Hoffacker, M. Helmreich, A. Wilisch, B. Vandekerckhove, T. Hunig, B. Schalke, C. Schneider, S. Tzartos, H. Kalbacher, H.K. Müller-Hermelink and A. Marx. 1998. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas. Lab. Invest. 78: 743.
Kirchner, T., B. Schalke, J. Buchwald, M. Ritter, A. Marx and H.K. Müller-Hermelink. 1992. Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am. J. Surg. Pathol. 16: 1153.
Kornstein, M.J., O. Asher, and S. Fuchs. 1995. Acetylcholine receptor alpha-subunit and myogenin mRNAs in thymus and thymomas. Am. J. Pathol. 146: 1320.
Kirchner, T., S. Tzartos, F. Hoppe, B. Schalke, H. Wekerle and H.K. Müller-Hermelink. 1988. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Am. J. Pathol. 130: 268.
Marx, A., R. O’Connor, K.I. Geuder, F. Hoppe, B. Schalke, S. Tzartos, I. Kalies, T. Kirchner and H.K. Müller-Hermelink. 1990. Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab. Invest. 62: 279.
Müller-Hermelink, H.K., A. Marx and T. Kirchner. 1994. Advances in the diagnosis and classification of thymic epithelial tumors. In Recent Advances in Histopathology. P. Anthony and R. MacSween, eds. Edinburgh, Churchill Livingstone, p. 49.
Masaoka, A., Y. Monden, K. Nakahara and T. Tanioka. 1981. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 48: 2485.
Kirchner, T., B. Schalke, A. Melms, T. von Kugelgen and H.K. Müller-Hermelink. 1986. Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis. Virchows. Arch. B. Cell. Pathol. Incl. Mol. Pathol. 52: 237.
Hämmerling, G., G. Schonrich, F. Momburg, N. Auphan, B. Malissen, A.M. Schmitt-Verhults and B. Arnold. 1991. Non-deletional mechanisms of peripheral and central tolerance: studies with transgenic mice with tissue-specific expression of a foreign MHC class I antigen. Immunol. Rev. 122: 47.
Naujokas, M.F., L.S. Arneson, B. Fineschi, M.E. Peterson, S. Sitterding, A.T. Hammond, C. Reilly, D. Lo and J. Miller. 1995. Potent effects of low levels of MHC class II-associated invariant chain on CD4+ T cell development. Immunity. 3: 359.
Pugliese, A., M. Zeller, A. Fernandez, Jr., L.J. Zalcberg, R.J. Bartlett, C. Ricordi, M. Pietropaolo, G.S. Eisenbarth, S.T. Bennett and D.D. Patel. 1997. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15: 293.
Vafiadis, P., S.T. Bennett, J.A. Todd, J. Nadeau, R. Grabs, C.G. Goodyer, S. Wickramasinghe, E. Colle and C. Polychronakos. 1997. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 15: 289.
Talib, S., T.B. Okarma and J.S. Lebkowski. 1993. Differential expression of human nicotinic acetylcholine receptor alpha subunit variants in muscle and non-muscle tissues. Nucleic. Acids. Res. 21: 233.
Andreetta, F., F. Baggi, C. Antozzi, E. Torchiana, P. Bernasconi, O. Simoncini, F. Comelio and R. Mantegazza. 1997. Acetylcholine receptor alpha-subunit isoforms are differentially expressed in thymuses from myasthenic patients. Am. J. Pathol. 150: 341.
Guyon, T., P. Levasseur, F. Truffault, C. Cottin, C. Gaud and S. Berrih Aknin. 1994. Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction. J. Clin. Invest. 94: 16.
Sommer, N., N. Willcox, G.C. Harcourt, and J. Newsom Davis. 1990. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann. Neurol. 28: 312.
Marx, A., A. Wilisch, A. Schultz, S. Gattenlöhner, R. Nenninger and H.K. Müller-Hermelink. 1997. Pathogenesis of Myasthenia gravis. Virchows Archive. 430: 355.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Gutsche, S. et al. (2000). Expression of the Acetylcholine Receptor α-Subunit Gene is Associated with Paraneoplastic Myasthenia Gravis in Mixed Thymoma. In: Christadoss, P. (eds) Myasthenia Gravis. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4060-7_5
Download citation
DOI: https://doi.org/10.1007/978-94-011-4060-7_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5787-5
Online ISBN: 978-94-011-4060-7
eBook Packages: Springer Book Archive